Browse
Submit Data
Databases
API
Help

Dataset Information

39 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

1,3,3-Trimethyl-1,2,3,4-tetra-hydro-pyrido[1,2-a]benzimidazol-1-ol.

ABSTRACT: In the title compound, C(14)H(18)N(2)O, the benzimidazole grouping is close to planar, with a maximum deviation of 0.042 Å; the six-membered non-aromatic ring adopts an envelope conformation. In the crystal structure, mol-ecules are linked into infinite sheets lying parallel to the bc plane by O-H⋯N and C-H⋯O hydrogen bonds.

SUBMITTER: Mehdi SH

PROVIDER: S-EPMC3006987 | biostudies-literature | 2010 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

1,3,3-Trimethyl-1,2,3,4-tetra-hydro-pyrido[1,2-a]benzimidazol-1-ol.

Mehdi Sayed Hasan SH Hashim Rokiah R Ghalib Raza Murad RM Yeap Chin Sing CS Fun Hoong-Kun HK

Acta crystallographica. Section E, Structure reports online 20100626 Pt 7

In the title compound, C(14)H(18)N(2)O, the benzimidazole grouping is close to planar, with a maximum deviation of 0.042 Å; the six-membered non-aromatic ring adopts an envelope conformation. In the crystal structure, mol-ecules are linked into infinite sheets lying parallel to the bc plane by O-H⋯N and C-H⋯O hydrogen bonds. ...[more]

PMID: 21588036

Similar Datasets

4-Phenyl-1,2,3,4-tetra-hydro-pyrimido[1,2-a]benzimidazol-2-one.

Project description:In the title compound, C(16)H(13)N(3)O, the tetrahydropyrimidin-one ring adopts a sofa conformation. In the crystal structure, mol-ecules are linked by N-H⋯N hydrogen bonds and C-H⋯π inter-actions.

| S-EPMC2959681 | biostudies-literature

(1R,4S)-7,8-Dichloro-1,2,3,4-tetra-hydro-1,11,11-trimethyl-1,4-methano-phenazine.

Project description:The title compound, C(16)H(16)Cl(2)N(2), was synthesized by the condensation reaction between 4,5-dichloro-o-phenyl-ene-diamine and (1R)-(-)-camphorquinone in boiling acetic acid. The two crystallographically independent mol-ecules in the unit cell are related by a pseudo-inversion center.

| S-EPMC3009136 | biostudies-literature

1,3,7-Trimethyl-2,4-dioxo-1,2,3,4-tetra-hydro-pteridine-6-carboxylic acid hemihydrate.

Project description:In the title compound, C(10)H(10)N(4)O(4)·0.5H(2)O, the two rings of the pteridine system are nearly coplanar [dihedral angle = 4.25 (9)°]. The atoms of the carboxyl group are also coplanar with the pteridine unit [r.m.s. deviation from the mean plane of the pteridine skeleton = 0.092 (2) Å]. In the crystal, the presence of the water molecule of crystallization (O atom site symmetry 2) leads to a hydrogen-bonding pattern different from the one shown by many carboxylic acid compounds (dimers formed through O-H⋯O hydrogen bonds between neighbouring carboxyl groups): in the present structure, the water mol-ecule, which lies on a binary axis, acts as a bridge between two mol-ecules, forming a hydrogen-bonded dimer. In addition to the hydrogen bonds, there are π-π ring stacking inter-actions involving the pyrimidine and pyrazine rings [centroid-centroid distance = 3.689 (1)Å], and two different pyrazine rings [centroid-centroid distance = 3.470 (1)Å]. Finally, there is a C-O⋯π contact involving a carboxyl-ate C-O and the pyrimidine ring with a short O⋯Cg distance of 2.738 (2) Å.

| S-EPMC2983745 | biostudies-literature

3,3-Dimethyl-1,2,3,4-tetra-hydro-cyclo-penta-[b]indole-1,2-dione (bruceolline E).

Project description:The title compound, C(13)H(11)NO(2), crystallizes with two mol-ecules in the asymmetric unit. The crystal packing is stabilized by N-H⋯O hydrogen bonds, which link the mol-ecules into chains along [10[Formula: see text]], and weak C-H⋯O inter-actions.

| S-EPMC3275045 | biostudies-literature

2-Bromo-1,6,6-trimethyl-6,7,8,9-tetra-hydro-phenanthro[1,2-b]furan-10,11-dione.

Project description:In the title compound, C19H17BrO3, the ring skeleton is located on a crystallographic mirror plane; two C atoms of the cyclo-hexene ring are disordered over the two locations to satisfy the preferred ring conformation. In the crystal, C-H⋯O hydrogen bonds link the mol-ecules into chains along the a axis. π-π stacking inter-actions between benzo-quinone rings, with a centroid-centroid distance of 3.7225 (4) Å, are also observed, which connect the chains into a two-dimensional networkparallel to the ab plane.

| S-EPMC3684922 | biostudies-literature

1,2,3,4-Tetra-hydro-phenazine 5,10-dioxide.

Project description:The complete mol-ecule of the title compound, C(12)H(12)N(2)O(2), lies on two crystallographic symmetry elements: a twofold axis and a mirror plane. In the mol-ecular structure, the quinoxaline ring and two methyl-ene substituents lie on the mirror plane while the other two methyl-ene groups are disordered about the plane. The crystal packing is stabilized by weak inter-molecular π-π stacking inter-actions with centroid-centroid distances of 3.6803 (7) Å.

| S-EPMC3008063 | biostudies-literature

1,2,3,4-Tetra-hydro-isoquinoline-2-sulfonamide.

Project description:The title compound, C(9)H(12)N(2)O(2)S, is a useful precursor of a variety of modified sulfonamide mol-ecules. Due to the importance of these mol-ecules in biological systems (antibacterials, antidepressants and many other applications), there is a growing inter-est in the discovery of new biologically active compounds. In the title compound, the mol-ecules are linked by N-H⋯O inter-molecular hydrogen bonds involving the sulfonamide function to form an infinite two-dimensional network parallel to the (001) plane.

| S-EPMC2960235 | biostudies-literature

Dichloridobis[2-(2-chloro-ethyl)-1,2,3,4-tetra-hydro-pyrazino[1,2-a]benzimidazole-κN]cobalt(II).

Project description:In the title compound, [CoCl(2)(C(12)H(14)ClN(3))(2)], the central Co(II) ion lies on a twofold rotation axis and adopts a distorted tetra-hedral coordination geometry defined by two N atoms from two 2-(2-chloro-ethyl)-1,2,3,4-tetra-hydro-pyrazino[1,2-a]benzimidazole ligands and two chloride anions. The Cl atom located in the side chain of the ligand is involved in inter-molecular C-H⋯Cl hydrogen bonding, which links neutral complex units into a one-dimensional right-handed helical chain running along a crystallographic 4(1) axis. Such hydrogen-bonded helical chains are connected to each other to form a homochiral three-dimensional supra-molecular network. One C atom of the 2-chloro-ethyl chain is disordered over two positions, with site-occupancy factors of 0.52 and 0.48.

| S-EPMC2961898 | biostudies-literature

Chloridobis(1,2,3,4-tetra-hydro-1,4,6,11-tetra-aza-naphthacene-?N)copper(I).

Project description:In the title complex, [CuCl(C(14)H(12)N(4))(2)], the Cu(I) atom, lying on a twofold rotation axis, is coordinated by two N atoms of two 1,2,3,4-tetra-hydro-1,4,6,11-tetra-aza-naphthacene ligands and one Cl atom, also lying on the twofold rotation axis, in a distorted trigonal-planar geometry. The complex mol-ecules are connected into a one-dimensional structure along [001] via N-H?N hydrogen bonds and further into a three-dimensional structure via N-H?Cl hydrogen bonds. ?-? inter-actions between the pyrazine and benzene rings and between the benzene rings [centroid-centroid distances = 3.5635?(15) and 3.9128?(16)?Å] are present.

| S-EPMC3297250 | biostudies-other

5-Methyl-3,6,7,8a-tetra-hydro-2H-diimidazo[1,2-c:1',2'-e]pyrido[1,2-a][1,3,5]triazin-5-ium iodide.

Project description:The structure of the title compound, C(12)H(16)N(5) (+)·I(-), shows that the methyl-ation reaction with CH(3)I occurred at the imine N atom at position 5 of the 3,6,7,8a-tetra-hydro-2H-diimidazo[1,2-c:1',2'-e]pyrido[1,2-a][1,3,5]triazine system. In the cation, the sp(3)-hybridized C atom belonging to the fused dihydro-pyrine and dihydro-1,3,5-triazine rings deviates by 0.514 (3) Å from the best plane defined by the remaining cationic non-H atoms. The fused dihydro-pyridine and dihydro-1,3,5-triazine rings are each in a half-chair conformation with the sp(3)-hybridized C atom as a flap. The iodide anion is 3.573 (2) Å from the methyl-ated N atom and exhibits five short C-H⋯I(-) contacts with distances less than 3.16 Å. The structure has been determined from a non-merohedral twin with twin law [-1 0 0 0 - 1 0 0.115 0 1], minor domain = 0.1559 (12).

| S-EPMC2979596 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data